AbbVie Inc.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…

Drug Manufacturers - General

US, North Chicago [HQ]

Lobbying · US Senate · Influence

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of AbbVie Inc. to fulfill lobbying activities in the United States of America.

FY	Quarter	Lobby Expense [in mil. $]	Filing	Report Time
2024	3	6	LDA-2	Oct. 19, 2024, 1:14 p.m.
2024	3	6	LDA-2	Oct. 18, 2024, 3:56 p.m.
2024	3	6	LDA-2	Oct. 17, 2024, 8:36 p.m.
2024	2	5	LDA-2	July 23, 2024, 3:19 a.m.
2024	2	5	LDA-2	July 22, 2024, 9:40 p.m.
2024	2	6	LDA-2	July 18, 2024, 6:42 p.m.
2024	2	6	LDA-2	July 18, 2024, 2:17 p.m.
2024	2	6	LDA-2	July 16, 2024, 3:39 a.m.
2024	1	5	LDA-2	April 23, 2024, 2:24 a.m.
2024	1	5	LDA-2	April 22, 2024, 10:58 p.m.
2024	1	6	LDA-2	April 19, 2024, 3:57 a.m.
2024	1	6	LDA-2	April 17, 2024, 10:51 p.m.
2024	1	6	LDA-2	April 17, 2024, 6:30 p.m.
2022	4	6	LDA-2	Feb. 7, 2024, 3:45 p.m.
2023	4	5	LDA-2	Jan. 23, 2024, 2:30 a.m.
2023	4	5	LDA-2	Jan. 22, 2024, 3:21 p.m.
2023	4	6	LDA-2	Jan. 20, 2024, 2:37 p.m.
2023	4	5	LDA-2	Jan. 19, 2024, 3:12 a.m.
2023	4	6	LDA-2	Jan. 15, 2024, 3:04 p.m.
2023	4	6	LDA-2	Jan. 13, 2024, 8:16 p.m.